Bleichroeder Acquisition Corp. II (Nasdaq: BBCQ), a Cayman Islands blank-check company, filed a Form 8-K with the Securities and Exchange Commission on August 6, 2026, reporting an event dated August 5. Filed under Item 8.01, Other Events, the disclosure is short and procedural, and it is the step that separates a de-SPAC that is being reviewed from one that is being voted on.

declared effective the registration statement on Form F-4 (File No. 333-296239)— Bleichroeder Acquisition Corp. II, Form 8-K filed August 6, 2026, source

The registration statement relates to Bleichroeder's proposed business combination with Pasqal Holding SAS, a French société par actions simplifiée. It was originally filed on May 26, 2026 and contains, as the filing puts it, a proxy statement of Bleichroeder and a prospectus of the Parent Merger Sub. Effectiveness means the SEC has completed its review; the proxy statement/prospectus can now go to shareholders and a meeting can be called. A press release announcing the milestone was attached as Exhibit 99.1.

The paper trail behind one sentence

The 8-K's explanatory note reconstructs a transaction that has been reworked repeatedly. The original Agreement and Plan of Merger was entered into on February 28, 2026, among Bleichroeder, an initial merger subsidiary organised in France, and Pasqal. Amendment No. 1, dated May 26, 2026, was an amendment and an assignment and assumption agreement, and it introduced a second French merger subsidiary — a société anonyme — as a party. Amendment No. 2 followed on June 25, 2026 and Amendment No. 3 on July 22, 2026, each between Bleichroeder, the Parent Merger Sub and Pasqal.

Three amendments in under five months, one of which changed the corporate form of the vehicle receiving the target, is a substantial amount of restructuring for a deal of this size. The filing does not say what any amendment changed. It also carries a small drafting artefact worth noting for anyone reading the note closely: the enumeration runs (i), (ii), (iii) and then (iii) again, so the July 22 amendment is numbered as though it were the June 25 one. The dates and defined terms are unambiguous; the roman numerals are not.

The instrument being used is a Form F-4 rather than an S-4, which follows from the target being a foreign private issuer — Pasqal is French, and the surviving public company will be the French Parent Merger Sub. That is a structural detail with consequences for the ongoing reporting regime the combined company will sit under, though the 8-K does not address them.

Effectiveness is worth defining precisely, because it is often read as more than it is. The SEC does not approve a transaction, endorse its terms or opine on its merits when it declares a registration statement effective. It concludes that the disclosure package meets the applicable requirements. The practical consequence is procedural and real: securities registered on the statement may be offered, the proxy statement/prospectus may be mailed, and the clock on a shareholder meeting can start. For a SPAC operating against a deadline to complete a combination, that clock is the binding constraint, and clearing review is the step most capable of consuming months.

What is not in the filing

A great deal. The 8-K states no transaction value, no pro-forma enterprise value, no share count and no ownership split. It gives no trust balance, no PIPE or other committed financing, no minimum-cash condition, and no date for the shareholder meeting or the expected closing. It describes nothing of Pasqal's business, revenue or technology. On a de-SPAC, those omissions are the substance of the deal, and they sit in the proxy statement/prospectus that has just become available rather than in the announcement that it did.

The risk factors the filing does enumerate are the standard set, and one of them is the operative variable here: the number of redemption requests. Bleichroeder's units, Class A ordinary shares and redeemable warrants trade as BBCQU, BBCQ and BBCQW; the warrants are exercisable at $11.50 per share. Between an effective registration statement and a closing sit a shareholder vote and a redemption window, and the filing lists among its risks the inability of the parties to consummate the combination and the failure to obtain shareholder or regulatory approvals. Bleichroeder identifies itself as an emerging growth company.

The counterparties are also worth locating. Bleichroeder Acquisition Corp. II is a Cayman Islands exempted company with offices at 1345 Avenue of the Americas in New York, and the initial merger subsidiary it formed in France was a société par actions simplifiée before Amendment No. 1 brought in a société anonyme as Parent Merger Sub. The société anonyme is the French form ordinarily required for a company whose shares are to be publicly held, which makes that amendment legible as preparation for a listed entity rather than as a change of commercial terms — an inference from corporate form, not from anything the filing says about why the change was made.

For readers tracking the quantum-computing cohort specifically, the useful point is that this is a status milestone and not a repricing. Nothing in the 8-K revises consideration, revises a valuation or discloses new financing. It records that the disclosure document is now available, which is exactly when the terms agreed in February and amended three times since become examinable in full.

What can be said from this document alone is narrow and worth stating precisely: a business combination agreed in February, amended three times, has cleared SEC review as of August 5, 2026, and the disclosure package is now public. Whether it closes, on what terms, and with how much cash surviving redemptions are questions this filing does not answer and does not attempt to.